Pirfenidone-Induced Sarcoid-Like Reaction A Novel Complication
被引:0
|
作者:
Kolaitis, Nicholas A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USAUniv Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
Kolaitis, Nicholas A.
[1
]
Kukreja, Jasleen
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USAUniv Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
Kukreja, Jasleen
[2
]
Jones, Kirk D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USAUniv Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
Jones, Kirk D.
[3
]
Hays, Steven R.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USAUniv Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
Hays, Steven R.
[1
]
Leard, Lorriana E.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USAUniv Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
Leard, Lorriana E.
[1
]
机构:
[1] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA
Idiopathic pulmonary fibrosis is the most common idiopathic interstitial pneumonia. Prognosis is poor with a median survival <3 years. Pirfenidone is one of two US Food and Drug Administration-approved medications that slow disease progression. We describe the development of lymphadenopathy or a sarcoid-like reaction following initiation of pirfenidone, a complication not previously reported.